We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TECHNE (Tech): "selling picks to gold miners"
TECH 77.81+3.1%3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: mopgcw2/2/2008 5:41:16 AM
  Read Replies (1) of 46
Techne - TECH-NNM
Outperform - Price 66.20 on Jan. 29
by Baird Securities

Techne is the leading producer of cytokine-related reagents and kits in the U.S. and biotechnology and hematology units. We're increasing our target from 70 to 71, based on a price/earnings multiple of 25 times (in line with 15-to-40 times we afford life-science companies) our calendar-year '09 EPS estimate of $2.82...we believe [the multiple] warranted, given Techne's industry-leading operating margins, strong cash flow, and strong balance sheet ($188.8 million of cash; no debt). Market-cap: $2.6 billion.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext